Skip to main content
. 2014 Dec 5;17(1):51–58. doi: 10.1111/jch.12449

Figure 1.

Figure 1

Comparison of total healthcare costs. The patients taking a fixed‐dose combination of amlodipine/valsartan (FDC) had significantly lower post‐index total healthcare costs (medical plus pharmacy costs). ARB+CCB indicates free combinations of angiotensin receptor blockers and calcium channel blockers; PDC, proportion of days covered. *P<.05.

[Correction added after initial online publication on December 5, 2014: Figure 1 has been revised.]